The University of Chicago Header Logo

Connection

Matthew Koshy to Humans

Back to Details
This is a "connection" page, showing publications Matthew Koshy has written about Humans.
Matthew Koshy
Connection Strength
1.002
Humans
  1. Increased Utilization of Stereotactic Body Radiotherapy is Associated with Decreased Disparities and Improved Survival for Early-Stage NSCLC. Clin Lung Cancer. 2023 01; 24(1):60-71.
    View in: PubMed
    Score: 0.029
  2. Increased Disparities in Patients Diagnosed with Metastatic Lung Cancer Following Lung CT Screening in the United States. Clin Lung Cancer. 2022 03; 23(2):151-158.
    View in: PubMed
    Score: 0.027
  3. The Risk Is Worth the Reward: Regional-Only Recurrence Is Curable with Nodal Dissection. Int J Radiat Oncol Biol Phys. 2020 02 01; 106(2):239-240.
    View in: PubMed
    Score: 0.024
  4. Adjuvant chemotherapy following stereotactic body radiotherapy for early stage non-small-cell lung cancer is associated with lower overall: A National Cancer Database Analysis. Lung Cancer. 2019 04; 130:162-168.
    View in: PubMed
    Score: 0.023
  5. Overall survival according to immunotherapy and radiation treatment for metastatic non-small-cell lung cancer: a National Cancer Database analysis. Radiat Oncol. 2019 Jan 28; 14(1):18.
    View in: PubMed
    Score: 0.023
  6. Survival outcomes for postoperative chemoradiation in intermediate-risk oral tongue cancers. Head Neck. 2017 12; 39(12):2537-2548.
    View in: PubMed
    Score: 0.021
  7. Association between hospital volume and receipt of treatment and survival in patients with glioblastoma. J Neurooncol. 2017 Dec; 135(3):529-534.
    View in: PubMed
    Score: 0.020
  8. Differences in Survival With Surgery and Postoperative Radiotherapy Compared With Definitive Chemoradiotherapy for Oral Cavity Cancer: A National Cancer Database Analysis. JAMA Otolaryngol Head Neck Surg. 2017 07 01; 143(7):691-699.
    View in: PubMed
    Score: 0.020
  9. Association between intensity modulated radiotherapy and survival in patients with stage III non-small cell lung cancer treated with chemoradiotherapy. Lung Cancer. 2017 06; 108:222-227.
    View in: PubMed
    Score: 0.020
  10. Impact of fraction size on locally advanced oropharyngeal and nasopharyngeal cancers treated with chemoradiation. Oral Oncol. 2017 05; 68:27-35.
    View in: PubMed
    Score: 0.020
  11. National patterns of care and predictors of neoadjuvant and concurrent chemotherapy use with definitive radiotherapy in the treatment of patients with oropharyngeal squamous cell carcinoma. Cancer. 2017 01 01; 123(2):273-282.
    View in: PubMed
    Score: 0.019
  12. Patterns of Care and Comparative Effectiveness of Intensified Adjuvant Therapy for Resected Oropharyngeal Squamous Cell Carcinoma in the Human Papillomavirus Era. JAMA Otolaryngol Head Neck Surg. 2016 08 01; 142(8):777-88.
    View in: PubMed
    Score: 0.019
  13. Patterns of care and survival outcomes examining radiation therapy for advanced Hodgkin lymphoma. Leuk Lymphoma. 2017 02; 58(2):343-347.
    View in: PubMed
    Score: 0.019
  14. The Benefit of Chemotherapy in Esophageal Cancer Patients With Residual Disease After Trimodality Therapy. Am J Clin Oncol. 2016 Apr; 39(2):136-41.
    View in: PubMed
    Score: 0.019
  15. Improved survival time trends in Hodgkin's lymphoma. Cancer Med. 2016 06; 5(6):997-1003.
    View in: PubMed
    Score: 0.019
  16. Comparative effectiveness of induction chemotherapy for oropharyngeal squamous cell carcinoma: A population-based analysis. Oral Oncol. 2016 Mar; 54:58-67.
    View in: PubMed
    Score: 0.018
  17. Response. J Natl Cancer Inst. 2016 Mar; 108(3).
    View in: PubMed
    Score: 0.018
  18. Prevalence and Predictors of Inappropriate Delivery of Palliative Thoracic Radiotherapy for Metastatic Lung Cancer. J Natl Cancer Inst. 2015 Dec; 107(12):djv278.
    View in: PubMed
    Score: 0.018
  19. Comparative effectiveness of aggressive thoracic radiation therapy and concurrent chemoradiation therapy in metastatic lung cancer. Pract Radiat Oncol. 2015 Nov-Dec; 5(6):374-82.
    View in: PubMed
    Score: 0.018
  20. In Reply to Levy et al. Int J Radiat Oncol Biol Phys. 2015 Jul 15; 92(4):946-7.
    View in: PubMed
    Score: 0.018
  21. Relationship Between Radiation Therapy Dose and Outcome in Patients Treated With Neoadjuvant Chemoradiation Therapy and Surgery for Stage IIIA Non-Small Cell Lung Cancer: A Population-Based, Comparative Effectiveness Analysis. Int J Radiat Oncol Biol Phys. 2015 Jun 01; 92(2):307-16.
    View in: PubMed
    Score: 0.017
  22. Comparative effectiveness of neoadjuvant chemoradiotherapy versus chemotherapy alone followed by surgery for patients with stage IIIA non-small cell lung cancer. Lung Cancer. 2015 Jun; 88(3):267-74.
    View in: PubMed
    Score: 0.017
  23. Disparities in treatment of patients with inoperable stage I non-small cell lung cancer: a population-based analysis. J Thorac Oncol. 2015 Feb; 10(2):264-71.
    View in: PubMed
    Score: 0.017
  24. Increasing radiation therapy dose is associated with improved survival in patients undergoing stereotactic body radiation therapy for stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2015 Feb 01; 91(2):344-50.
    View in: PubMed
    Score: 0.017
  25. Risk of second malignancies in patients with early-stage classical Hodgkin's lymphoma treated in a modern era. Cancer Med. 2015 Apr; 4(4):513-8.
    View in: PubMed
    Score: 0.017
  26. Stereotactic body radiotherapy and treatment at a high volume facility is associated with improved survival in patients with inoperable stage I non-small cell lung cancer. Radiother Oncol. 2015 Feb; 114(2):148-54.
    View in: PubMed
    Score: 0.017
  27. The effect of radiotherapy dose on survival in stage III non-small-cell lung cancer patients undergoing definitive chemoradiotherapy. Clin Lung Cancer. 2014 Sep; 15(5):365-71.
    View in: PubMed
    Score: 0.016
  28. An analysis of radiation necrosis of the central nervous system treated with bevacizumab. J Neurooncol. 2014 Apr; 117(2):321-7.
    View in: PubMed
    Score: 0.016
  29. Clinical outcomes for gastric cancer following adjuvant chemoradiation utilizing intensity modulated versus three-dimensional conformal radiotherapy. PLoS One. 2014; 9(1):e82642.
    View in: PubMed
    Score: 0.016
  30. In response. J Thorac Oncol. 2013 Nov; 8(11):e101.
    View in: PubMed
    Score: 0.016
  31. In response. J Thorac Oncol. 2013 Nov; 8(11):e99-100.
    View in: PubMed
    Score: 0.016
  32. Long-term outcomes in patients with early stage nodular lymphocyte-predominant Hodgkin's lymphoma treated with radiotherapy. PLoS One. 2013; 8(9):e75336.
    View in: PubMed
    Score: 0.016
  33. Improved survival associated with neoadjuvant chemoradiation in patients with clinical stage IIIA(N2) non-small-cell lung cancer. J Thorac Oncol. 2013 Jul; 8(7):915-22.
    View in: PubMed
    Score: 0.015
  34. An analysis of patient characteristics and clinical outcomes in primary pulmonary sarcoma. J Thorac Oncol. 2013 Feb; 8(2):147-51.
    View in: PubMed
    Score: 0.015
  35. Improved survival time trends for glioblastoma using the SEER 17 population-based registries. J Neurooncol. 2012 Mar; 107(1):207-12.
    View in: PubMed
    Score: 0.014
  36. Is computed tomography simulation associated with improved survival, or is this finding a result of confounding variables? J Clin Oncol. 2011 Sep 10; 29(26):3587; author reply 3587-8.
    View in: PubMed
    Score: 0.013
  37. Post-operative radiation improves survival in children younger than 3 years with intracranial ependymoma. J Neurooncol. 2011 Dec; 105(3):583-90.
    View in: PubMed
    Score: 0.013
  38. Outcomes after trimodality therapy for esophageal cancer: the impact of histology on failure patterns. Am J Clin Oncol. 2011 Jun; 34(3):259-64.
    View in: PubMed
    Score: 0.013
  39. Declining use of radiotherapy in stage I and II Hodgkin's disease and its effect on survival and secondary malignancies. Int J Radiat Oncol Biol Phys. 2012 Feb 01; 82(2):619-25.
    View in: PubMed
    Score: 0.013
  40. Impact of neoadjuvant radiation on survival in stage III non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2011 Apr 01; 79(5):1388-94.
    View in: PubMed
    Score: 0.012
  41. A novel technique for post-mastectomy breast irradiation utilising non-coplanar intensity-modulated radiation therapy. Br J Radiol. 2010 Oct; 83(994):874-81.
    View in: PubMed
    Score: 0.012
  42. Improved survival with radiation therapy in high-grade soft tissue sarcomas of the extremities: a SEER analysis. Int J Radiat Oncol Biol Phys. 2010 May 01; 77(1):203-9.
    View in: PubMed
    Score: 0.012
  43. Primary MALT lymphoma of the gallbladder. Case report. J Gastrointestin Liver Dis. 2008 Jun; 17(2):207-10.
    View in: PubMed
    Score: 0.011
  44. Radiation-induced osteosarcomas in the pediatric population. Int J Radiat Oncol Biol Phys. 2005 Nov 15; 63(4):1169-74.
    View in: PubMed
    Score: 0.009
  45. The importance of considering competing risks in recurrence analysis of intracranial meningioma. J Neurooncol. 2024 Feb; 166(3):503-511.
    View in: PubMed
    Score: 0.008
  46. Decreased overall survival in patients with locally advanced head and neck cancer receiving definitive radiotherapy and concurrent cetuximab: National Cancer Database analysis. Head Neck. 2022 07; 44(7):1528-1544.
    View in: PubMed
    Score: 0.007
  47. Development and Validation of a Decision Analytical Model for Posttreatment Surveillance for Patients With Oropharyngeal Carcinoma. JAMA Netw Open. 2022 04 01; 5(4):e227240.
    View in: PubMed
    Score: 0.007
  48. Addressing Sex Disparities in Lung Cancer Screening Eligibility: USPSTF vs PLCOm2012 Criteria. Chest. 2022 01; 161(1):248-256.
    View in: PubMed
    Score: 0.007
  49. Impact of anatomic site of distant metastasis on survival in salivary gland cancers. Head Neck. 2021 09; 43(9):2589-2601.
    View in: PubMed
    Score: 0.007
  50. Patterns of Care and Survival Outcomes for Odontogenic Cancers. Laryngoscope. 2021 05; 131(5):E1496-E1502.
    View in: PubMed
    Score: 0.006
  51. Machine Learning-Guided Adjuvant Treatment of Head and Neck Cancer. JAMA Netw Open. 2020 11 02; 3(11):e2025881.
    View in: PubMed
    Score: 0.006
  52. Risk Prediction Model Versus United States Preventive Services Task Force Lung Cancer Screening Eligibility Criteria: Reducing Race Disparities. J Thorac Oncol. 2020 11; 15(11):1738-1747.
    View in: PubMed
    Score: 0.006
  53. Prostate Cancer Outcomes Following Solid-Organ Transplantation: A SEER-Medicare Analysis. J Natl Cancer Inst. 2020 08 01; 112(8):847-854.
    View in: PubMed
    Score: 0.006
  54. Frame-based radiosurgery of multiple metastases using single-isocenter volumetric modulated arc therapy technique. J Appl Clin Med Phys. 2019 Aug; 20(8):21-28.
    View in: PubMed
    Score: 0.006
  55. Outcomes From a Minority-Based Lung Cancer Screening Program vs the National Lung Screening Trial. JAMA Oncol. 2018 09 01; 4(9):1291-1293.
    View in: PubMed
    Score: 0.005
  56. Malignant Peritoneal Mesothelioma: National Practice Patterns, Outcomes, and Predictors of Survival. Ann Surg Oncol. 2018 Jul; 25(7):2018-2026.
    View in: PubMed
    Score: 0.005
  57. Haploidentical Peripheral Blood Stem Cell Transplantation Demonstrates Stable Engraftment in Adults with Sickle Cell Disease. Biol Blood Marrow Transplant. 2018 08; 24(8):1759-1765.
    View in: PubMed
    Score: 0.005
  58. Palliative thoracic radiation therapy for non-small cell lung cancer: 2018 Update of an American Society for Radiation Oncology (ASTRO) Evidence-Based Guideline. Pract Radiat Oncol. 2018 Jul - Aug; 8(4):245-250.
    View in: PubMed
    Score: 0.005
  59. Radiosurgery alone is associated with favorable outcomes for brain metastases from small-cell lung cancer. Lung Cancer. 2018 06; 120:88-90.
    View in: PubMed
    Score: 0.005
  60. Post-Treatment Mortality After Surgery and Stereotactic Body Radiotherapy for Early-Stage Non-Small-Cell Lung Cancer. J Clin Oncol. 2018 03 01; 36(7):642-651.
    View in: PubMed
    Score: 0.005
  61. A phase 1 trial of autologous stem cell transplantation conditioned with melphalan 200?mg/m2 and total marrow irradiation (TMI) in patients with relapsed/refractory multiple myeloma. Leuk Lymphoma. 2018 07; 59(7):1666-1671.
    View in: PubMed
    Score: 0.005
  62. Reply to Tumor localization may change the type of adjuvant treatment in gastric cancer. Cancer. 2017 12 01; 123(23):4737-4738.
    View in: PubMed
    Score: 0.005
  63. Effect of Endoscopic Bronchial Ultrasound on Outcomes for Stage I Non-Small-Cell Lung Cancer Patients Receiving Hypofractionated Radiotherapy. Clin Lung Cancer. 2018 03; 19(2):e227-e233.
    View in: PubMed
    Score: 0.005
  64. Radiation plus Temozolomide in Patients with Glioblastoma. N Engl J Med. 2017 06 01; 376(22):2195-2197.
    View in: PubMed
    Score: 0.005
  65. Adjuvant radiotherapy improves overall survival in patients with resected gastric adenocarcinoma: A National Cancer Data Base analysis. Cancer. 2017 Sep 01; 123(17):3402-3409.
    View in: PubMed
    Score: 0.005
  66. Metastatic nasopharyngeal carcinoma: Patterns of care and survival for patients receiving chemotherapy with and without local radiotherapy. Radiother Oncol. 2017 07; 124(1):139-146.
    View in: PubMed
    Score: 0.005
  67. The prognostic value of extranodal extension in human papillomavirus-associated oropharyngeal squamous cell carcinoma. Cancer. 2017 Jul 15; 123(14):2762-2772.
    View in: PubMed
    Score: 0.005
  68. Insurance Status and Racial Disparities in Cancer-Specific Mortality in the United States: A Population-Based Analysis. Cancer Epidemiol Biomarkers Prev. 2017 06; 26(6):869-875.
    View in: PubMed
    Score: 0.005
  69. The Impact of Postoperative Radiotherapy for Thymoma and Thymic Carcinoma. J Thorac Oncol. 2017 04; 12(4):734-744.
    View in: PubMed
    Score: 0.005
  70. Weekly versus every-three-weeks platinum-based chemoradiation regimens for head and neck cancer. J Otolaryngol Head Neck Surg. 2016 Nov 24; 45(1):62.
    View in: PubMed
    Score: 0.005
  71. Combined-Modality Therapy With Radiation and Chemotherapy for Elderly Patients With Glioblastoma in the Temozolomide Era: A National Cancer Database Analysis. JAMA Neurol. 2016 07 01; 73(7):821-8.
    View in: PubMed
    Score: 0.005
  72. Limitations of PET/CT in the Detection of Occult N1 Metastasis in Clinical Stage I(T1-2aN0) Non-Small Cell Lung Cancer for Staging Prior to Stereotactic Body Radiotherapy. Technol Cancer Res Treat. 2017 02; 16(1):15-21.
    View in: PubMed
    Score: 0.005
  73. Improved Survival With Prostate Radiation in Addition to Androgen Deprivation Therapy for Men With Newly Diagnosed Metastatic Prostate Cancer. J Clin Oncol. 2016 08 20; 34(24):2835-42.
    View in: PubMed
    Score: 0.005
  74. A preplanning method for stereotactic radiosurgery to improve treatment workflow. J Appl Clin Med Phys. 2016 05 08; 17(3):171-179.
    View in: PubMed
    Score: 0.005
  75. A brighter future? The impact of insurance and socioeconomic status on cancer outcomes in the USA: a review. Future Oncol. 2016 Jun; 12(12):1507-15.
    View in: PubMed
    Score: 0.005
  76. Anatomical contouring variability in thoracic organs at risk. Med Dosim. 2016 Winter; 41(4):344-350.
    View in: PubMed
    Score: 0.005
  77. Nonmyeloablative Stem Cell Transplantation with Alemtuzumab/Low-Dose Irradiation to Cure and Improve the Quality of Life of Adults with Sickle Cell Disease. Biol Blood Marrow Transplant. 2016 Mar; 22(3):441-8.
    View in: PubMed
    Score: 0.004
  78. Impact of Insurance Status on Radiation Treatment Modality Selection Among Potential Candidates for Prostate, Breast, or Gynecologic Brachytherapy. Int J Radiat Oncol Biol Phys. 2015 Dec 01; 93(5):968-75.
    View in: PubMed
    Score: 0.004
  79. A multi-institutional study to assess adherence to lung stereotactic body radiotherapy planning goals. Med Phys. 2015 Aug; 42(8):4629-35.
    View in: PubMed
    Score: 0.004
  80. Changes in brachytherapy-based APBI patient selection immediately before and after publication of the ASTRO consensus statement. Brachytherapy. 2015 Jul-Aug; 14(4):490-5.
    View in: PubMed
    Score: 0.004
  81. Variation in insurance status by patient demographics and tumor site among nonelderly adult patients with cancer. Cancer. 2015 Jun 15; 121(12):2020-8.
    View in: PubMed
    Score: 0.004
  82. Combination of linear accelerator-based intensity-modulated total marrow irradiation and myeloablative fludarabine/busulfan: a phase I study. Biol Blood Marrow Transplant. 2014 Dec; 20(12):2034-41.
    View in: PubMed
    Score: 0.004
  83. Disparities in stage at diagnosis, treatment, and survival in nonelderly adult patients with cancer according to insurance status. J Clin Oncol. 2014 Oct 01; 32(28):3118-25.
    View in: PubMed
    Score: 0.004
  84. Influence of conformal radiotherapy technique on survival after chemoradiotherapy for patients with stage III non-small cell lung cancer in the National Cancer Data Base. Cancer. 2014 Jul 01; 120(13):2060-8.
    View in: PubMed
    Score: 0.004
  85. Radiation oncology medical student clerkship: implementation and evaluation of a bi-institutional pilot curriculum. Int J Radiat Oncol Biol Phys. 2014 Jan 01; 88(1):45-50.
    View in: PubMed
    Score: 0.004
  86. A national radiation oncology medical student clerkship survey: didactic curricular components increase confidence in clinical competency. Int J Radiat Oncol Biol Phys. 2014 Jan 01; 88(1):51-6.
    View in: PubMed
    Score: 0.004
  87. Declining use of brachytherapy for the treatment of prostate cancer. Brachytherapy. 2014 Mar-Apr; 13(2):157-62.
    View in: PubMed
    Score: 0.004
  88. Increasing national mastectomy rates for the treatment of early stage breast cancer. Ann Surg Oncol. 2013 May; 20(5):1436-43.
    View in: PubMed
    Score: 0.004
  89. Radiation oncology fourth-year medical student clerkships: a targeted needs assessment. Int J Radiat Oncol Biol Phys. 2013 Feb 01; 85(2):296-7.
    View in: PubMed
    Score: 0.004
  90. Similar survival with breast conservation therapy or mastectomy in the management of young women with early-stage breast cancer. Int J Radiat Oncol Biol Phys. 2012 Aug 01; 83(5):1387-93.
    View in: PubMed
    Score: 0.003
  91. Adjuvant radiation therapy for high-grade and/or locally advanced major salivary gland tumors. Arch Otolaryngol Head Neck Surg. 2011 Oct; 137(10):1025-30.
    View in: PubMed
    Score: 0.003
  92. Squamous cell carcinoma of the esophagus: treat with how many modalities? Semin Oncol. 2009 Dec; 36(6):493-7.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.